Halimed Pharmaceuticals, Inc.

Mount Pleasant, SC 29464

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $4MM
First Award Date 08/18/10
Most Recent Award Date 08/01/14

Key Personnel

Last Name Name Awards Contact
Dix Thomas A Dix 6
Yu Shan Ping Yu 2

6 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 08/01/14 - 07/31/15

DESCRIPTION (provided by applicant): Treatment of peripheral pain of various origins remains a major unmet medical need, affecting tens to hundreds of millions of people nationwide at some time during their lives. Kappa-opioid agonists have been shown in peripheral pain models to be particularly efficacious but suffer from centrally mediated eff...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-10-051
Budget: 09/01/12 - 08/31/13

DESCRIPTION (provided by applicant): Stroke is the third leading cause of death in the United States. In spite of intensive investigations, clinical therapies for treating acute stroke patients remain limited and unsatisfactory. There are consistent animal and human data that mild to moderate hypothermia (reducing body temperature to 32-34oC)...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 08/01/12 - 07/31/13

DESCRIPTION (provided by applicant): This is the follow-on Phase II SBIR proposal to continue the project "Novel Neurotensin Analogs as Antischizophrenics" (MH-65099) under PA-06-079 (Pharmacological Agents and Drugs for Mental Disorders). There exists a critical clinical need for the identification and development of novel therapies for psychos...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-10-051
Budget: 09/30/11 - 08/31/12

DESCRIPTION (provided by applicant): Stroke is the third leading cause of death in the United States. In spite of intensive investigations, clinical therapies for treating acute stroke patients remain limited and unsatisfactory. There are consistent animal and human data that mild to moderate hypothermia (reducing body temperature to 32-34oC)...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 08/30/11 - 07/31/12

DESCRIPTION (provided by applicant): This is the follow-on Phase II SBIR proposal to continue the project "Novel Neurotensin Analogs as Antischizophrenics" (MH-65099) under PA-06-079 (Pharmacological Agents and Drugs for Mental Disorders). There exists a critical clinical need for the identification and development of novel therapies for psychos...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 08/18/10 - 07/31/11

DESCRIPTION (provided by applicant): This is the follow-on Phase II SBIR proposal to continue the project "Novel Neurotensin Analogs as Antischizophrenics" (MH-65099) under PA-06-079 (Pharmacological Agents and Drugs for Mental Disorders). There exists a critical clinical need for the identification and development of novel therapies for psychos...